Open access · US-GOV via ClinicalTrials.gov Clinical trial

Sarcopenia and Related Factors in COVID-19 Following Intensive Care

Authors not listed

Koç University · 2021

Dysbiosis Human Randomized controlled trial

Abstract

The primary aim of this study is to evaluate the patients who had pneumonia or severe acute respiratory distress syndrome (ARDS) due to COVID-19 in terms of sarcopenia and related factors following Intensive Care Unit (ICU). The patients who had COVID-19 infection in the ICU and the patients who admitted to the 'Physical Medicine and Rehabilitation' clinic for other reasons during the pandemic period will be compared in terms of sarcopenia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2021). Sarcopenia and Related Factors in COVID-19 Following Intensive Care. <em>Koç University</em>. https://clinicaltrials.gov/study/NCT05474157

Vancouver

Anonymous. Sarcopenia and Related Factors in COVID-19 Following Intensive Care. Koç University. 2021.

BibTeX

@misc{anon2021Sarcop, title = {Sarcopenia and Related Factors in COVID-19 Following Intensive Care}, author = {Anonymous}, journal = {Koç University}, year = {2021}, }